At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Not Yet Opened 12-22 16:00:00 EST
1,697.32
-0.21
-0.01%
High1,703.84Low1,682.18Vol27.19M
Open1,694.29D1 Closing1,697.53Amplitude1.28%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O1.08BT/O Rate--Tradable Shares0.00
P/B4.119356ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
Dow Jones  ·  06:27
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
Gilead Sciences Executives to Present at J.P. Morgan Healthcare Conference
Reuters  ·  05:05
Gilead Sciences Executives to Present at J.P. Morgan Healthcare Conference
BUZZ-Assembly Biosciences rises as Gilead opts to license co's HSV therapies
Reuters  ·  01:27
BUZZ-Assembly Biosciences rises as Gilead opts to license co's HSV therapies
US Medicaid Program Will Hit Swiss Wallets Hard, Roche CEO Says
Benzinga_recent_news  ·  12-22 21:43
US Medicaid Program Will Hit Swiss Wallets Hard, Roche CEO Says
BRIEF-Gilead Sciences Exercises Option To License Assembly Biosciences’ Helicase-Primase Inhibitor Programs For Recurrent Genital Herpes
Reuters  ·  12-22 21:20
BRIEF-Gilead Sciences Exercises Option To License Assembly Biosciences’ Helicase-Primase Inhibitor Programs For Recurrent Genital Herpes
Gilead - Assembly Bio to Receive $35 Mln for Gilead's Hsv Option
THOMSON REUTERS  ·  12-22 21:00
Gilead - Assembly Bio to Receive $35 Mln for Gilead's Hsv Option
Opus Genetics Inc - on Dec 17, Viatris Files Supplemental Nda With FDA for Phentolamine - SEC Filing
THOMSON REUTERS  ·  12-20
Opus Genetics Inc - on Dec 17, Viatris Files Supplemental Nda With FDA for Phentolamine - SEC Filing
Inovio Grants Stock Options to New Hire Under 2022 Inducement Plan
Reuters  ·  12-20
Inovio Grants Stock Options to New Hire Under 2022 Inducement Plan
Shares of Some U.S. Drugmakers Rise After Signing Drug Pricing Deal With President Trump
THOMSON REUTERS  ·  12-20
Shares of Some U.S. Drugmakers Rise After Signing Drug Pricing Deal With President Trump
Shares of Bristol Myers Squibb up 1.8%, Gilead Sciences up 2.9%, Amgen and Merck up Nearly 1%
THOMSON REUTERS  ·  12-20
Shares of Bristol Myers Squibb up 1.8%, Gilead Sciences up 2.9%, Amgen and Merck up Nearly 1%
Quest Diagnostics Executives to Present Strategy at J.P. Morgan Healthcare Conference
Reuters  ·  12-20
Quest Diagnostics Executives to Present Strategy at J.P. Morgan Healthcare Conference
Gilead Sciences Signs Deal With US Government to Lower Drug Costs
MT Newswires Live  ·  12-20
Gilead Sciences Signs Deal With US Government to Lower Drug Costs
Trump: Meeting in Coming Weeks
THOMSON REUTERS  ·  12-20
Trump: Meeting in Coming Weeks
Trump: Insurance Company Meeting to GET Their Prices Down
THOMSON REUTERS  ·  12-20
Trump: Insurance Company Meeting to GET Their Prices Down
Trump: I Will Call Meeting of Insurance Companies
THOMSON REUTERS  ·  12-20
Trump: I Will Call Meeting of Insurance Companies
Trump: We Could GET Insurance Companies to Cut Prices to Stay in System
THOMSON REUTERS  ·  12-20
Trump: We Could GET Insurance Companies to Cut Prices to Stay in System
Trump: Johnson and Johnson and Four Other Companies Will Be Coming in Next Week, They've Agreed to Lowest Price in World
THOMSON REUTERS  ·  12-20
Trump: Johnson and Johnson and Four Other Companies Will Be Coming in Next Week, They've Agreed to Lowest Price in World
Bristol Myers Squibb Says Its Donation to Strategic Reserve Will Include Top Selling Blood Thinner Eliquis
THOMSON REUTERS  ·  12-20
Bristol Myers Squibb Says Its Donation to Strategic Reserve Will Include Top Selling Blood Thinner Eliquis
Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies
MT Newswires Live  ·  12-20
Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies
Trump: the 3 of the 17 Pharmaceutical Companies Who Have Not Agreed Are Coming in Next Week
THOMSON REUTERS  ·  12-20
Trump: the 3 of the 17 Pharmaceutical Companies Who Have Not Agreed Are Coming in Next Week

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--